GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

ProMIS Neurosciences PMN · USD

Health Care · US listing · 🇺🇸 United States

Compare

4.05

-2.64%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2023

Revenue

—

FY2014FY2023

Net income

−$13.2m

FY2014FY2023

Free cash flow

−$10.8m

FY2014FY2023

Shareholders' equity

$3.8m

FY2014FY2023

Income statement

Fiscal years

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue——————$10,000—$20,000$230,000
Research and development$7.9m$16.1m$4.6m$2.4m$3.6m$5.7m$3.0m$1.4m$830,000$1.2m
Operating income−$14.3m−$23.4m−$8.3m−$4.2m−$5.6m−$7.8m−$4.6m−$2.6m−$1.6m−$1.9m
Net income−$13.2m−$18.1m−$9.8m−$4.2m−$5.6m−$7.8m−$4.6m−$2.6m−$1.7m−$1.9m
Diluted earnings per share-26.87-60.17-42.31-22.15-32.21-49.15-33.81-23.03-23.05-42.76

Balance sheet

At each fiscal year end

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$13.6m$6.9m$17.8m$1.1m$1.6m$2.2m$1.7m$720,000$830,000$250,000
Cash and short-term investments$12.6m$5.9m$17.0m$840,000$1.3m$1.8m$1.4m$560,000$680,000$20,000
Total liabilities$9.9m$8.3m$12.1m$1.9m$1.3m$1.3m$510,000$670,000$400,000$420,000
Debt——$3.9m————$90,000$90,000—
Shareholders' equity$3.8m−$1.4m$5.7m−$800,000$310,000$850,000$1.2m$50,000$430,000−$170,000
Shares outstanding0m0m0m0m0m0m0m0m0m0m

Cash flow

Fiscal years

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations−$10.8m−$17.0m−$9.3m−$3.3m−$4.6m−$6.7m−$4.4m−$1.9m−$1.2m−$1.2m
Capital spending——−$10,000−$80,000——————
Free cash flow−$10.8m−$17.0m−$9.3m−$3.3m−$4.6m−$6.7m−$4.4m−$1.9m−$1.2m−$1.2m

Latest quarters

By quarter end

Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
Operating income−$11.8m−$10.2m−$7.5m−$6.0m−$4.4m−$2.7m−$3.7m−$3.9m
Net income−$11.6m−$10.1m−$7.3m−$238,200$9.3m−$2.6m−$3.6m−$3.6m
Diluted earnings per share-5.93-7.26-5.27-0.167.71-3.31-4.65-4.57
Cash from operations−$10.0m−$3.0m−$4.0m−$8.0m−$6.0m−$1.0m−$10.0m−$3.0m
Total assets$21.5m$9.5m$13.6m$18.9m$24.5m$1.4m$3.5m$13.6m
Cash and short-term investments$15.4m$4.5m$8.4m$13.3m$21.6m$1.0m$2.5m$12.6m
Shareholders' equity$9.2m−$382,600$9.5m$16.5m$7.3m−$2.3m$77,100$3.8m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income50.1%12.7%20.9%
Net income46.3%11.0%20.0%

Valuation history

At each fiscal year end

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Price to earnings-0.5-0.8-1.7-2.4-2.6-2.7-3.3-2.8-1.1-0.4
Price to sales————————94.33.3

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-62%-21%-77%-20%67%-57%-18%6%60%150%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 25-to-1 reverse split · 28 Nov 2025
  • 60-to-1 reverse split · 28 Jun 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.